E. Claus, M. Bondy, and J. Schildkraut, Epidemiology of Intracranial Meningioma, Neurosurgery, vol.7, issue.6, pp.1088-1095, 2005.
DOI : 10.1269/jrr.40.49

X. Gao, R. Zhang, Y. Mao, and Y. Wang, Childhood and juvenile meningiomas, Child's Nervous System, vol.11, issue.255, pp.1571-1580, 2009.
DOI : 10.1016/S0344-0338(00)80050-3

K. Zülch, Histological typing of tumours of the central nervous system. World Health Organization, 1979.

D. Louis, S. B. Budka, H. Von-deimling, A. Kepes, J. et al., World Health Organization Classification of Tumours. Pathology and genetics. Tumour of the nervous system, pp.175-184, 2000.

D. Louis, The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathologica, vol.45, issue.6, p.2016
DOI : 10.1038/ng.2611

URL : https://hal.archives-ouvertes.fr/hal-01479018

I. Baldia, Epidemiology of meningiomas, Neurochirurgie, vol.64, issue.1
DOI : 10.1016/j.neuchi.2014.05.006

N. Dri, D. , B. Ismail, M. François, P. Jan et al., Analyse du devenir post-opératoire des méningiomes intracrâniens

S. Zouaoui, Recensement national histologique des tumeurs primitives du syst??me nerveux central??: r??sultats g??n??raux sur 40??000??cas, principales applications actuelles et perspectives, Neurochirurgie, vol.58, issue.1, pp.4-13, 2012.
DOI : 10.1016/j.neuchi.2012.01.004

URL : https://doi.org/10.1016/j.neuchi.2012.01.004

J. Ruiz, A. Martinez, and S. Hernandez, Clinicopathological variables, immune phenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II, Histol Histopathol, vol.25, pp.341-349, 2010.

S. Adeberg, C. Hartmann, and T. Welzel, Long-Term Outcome After Radiotherapy in Patients With Atypical and Malignant Meningiomas???Clinical Results in 85 Patients Treated in a Single Institution Leading to Optimized Guidelines for Early Radiation Therapy, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.859-864, 2012.
DOI : 10.1016/j.ijrobp.2011.08.010

R. Goldbrunner, EANO guidelines for the diagnosis and treatment of meningiomas, The Lancet Oncology, vol.17, issue.9, pp.383-91, 2016.
DOI : 10.1016/S1470-2045(16)30321-7

I. R. Whittle, Meningiomas, The Lancet, vol.363, issue.9420, pp.1535-1578, 2004.
DOI : 10.1016/S0140-6736(04)16153-9

M. I. Vargas, Les m??ningiomes rachidiens extraduraux : Donn??es IRM ?? propos de deux observations, Journal of Neuroradiology, vol.31, issue.3, pp.31214-219, 2004.
DOI : 10.1016/S0150-9861(04)96994-5

A. Surov, Distant metastases in meningioma: an underestimated problem Journal of Neuro-Oncology, pp.323-327, 2013.

A. Enam, Metastasis in meningioma Neuropathologies des tumeurs intra-crâniennes http, Acta Neurochirurgica, vol.13817, issue.10, pp.1172-1178, 1996.

M. Sanson, Données générales de neuro-oncogenèse, pp.75-89, 2004.

H. Zankl and K. Zang, Cytological and cytogenetical studies on brain tumors, Humangenetik, vol.12, issue.2, pp.167-169, 1972.
DOI : 10.1007/BF00273305

W. Bi, Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications, Frontiers in Surgery, vol.19, issue.19, p.40, 2016.
DOI : 10.1158/1078-0432.CCR-13-0143

R. Weber, Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression, Proceedings of the National Academy of Sciences, vol.56, issue.11, pp.9414719-14724, 1997.
DOI : 10.1038/ng0495-401

M. Peyre and M. Kalamarides, Molecular genetics of meningiomas: Building the roadmap towards personalized therapy, Neurochirurgie, vol.64, issue.1, 2014.
DOI : 10.1016/j.neuchi.2014.06.007

T. Okada, Shedding light on Merlin's wizardry, Trends in Cell Biology, vol.17, issue.5, 2007.
DOI : 10.1016/j.tcb.2007.03.006

J. Rockhill, M. Mrugala, and M. Chamberlain, Intracranial meningiomas: an overview of diagnosis and treatment, Neurosurgical Focus, vol.345, issue.3, p.1, 2007.
DOI : 10.1002/1097-0142(20000901)89:5<1102::AID-CNCR20>3.0.CO;2-L

D. Saloner, Modern meningioma imaging techniques, Journal of Neuro-Oncology, vol.50, issue.1, pp.333-340, 2010.
DOI : 10.1007/s11060-010-0367-6

URL : https://link.springer.com/content/pdf/10.1007%2Fs11060-010-0367-6.pdf

Y. Ding, Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas, Ann Clin Lab Sci. Autumn, vol.38, issue.4, pp.344-51, 2008.

T. Graillon, Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review, Journal of Neurosurgery, vol.8, issue.3, pp.660-669, 2017.
DOI : 10.1073/pnas.1102198108

URL : https://hal.archives-ouvertes.fr/hal-01478922

J. Bruna, Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma, Neuropathology, vol.20, issue.2, pp.114-134, 2007.
DOI : 10.1007/BF01476410

M. Preusser, Advances in meningioma genetics: novel therapeutic opportunities, Nature Reviews Neurology, vol.11, issue.2, 2018.
DOI : 10.1016/j.ccr.2013.01.008

M. Smith, O. Sullivan, J. Bhaskar, S. Hadfield, K. Poke et al., Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas, Nature Genetics, vol.12, issue.3, pp.295-303, 2013.
DOI : 10.1002/lary.20430

M. Aavikko, S. Li, S. Saarinen, P. Alhopuro, E. Kaasinen et al., Loss of SUFU Function in Familial Multiple Meningioma, The American Journal of Human Genetics, vol.91, issue.3, pp.520-526, 2012.
DOI : 10.1016/j.ajhg.2012.07.015

I. Christiaans, S. Kenter, H. Brink, T. Van-os, F. Baas et al., Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas, Journal of Medical Genetics, vol.48, issue.2, pp.93-100, 2011.
DOI : 10.1136/jmg.2010.082420

URL : https://hal.archives-ouvertes.fr/hal-00573999

A. Asthagiri, D. Parry, and J. Butman, Neurofibromatosis type 2, The Lancet, vol.373, issue.9679, pp.1974-1986, 2009.
DOI : 10.1016/S0140-6736(09)60259-2

M. Peyre and M. Kalamarides, Molecular genetics of meningiomas: Building the roadmap towards personalized therapy, Neurochirurgie, vol.64, issue.1, 2014.
DOI : 10.1016/j.neuchi.2014.06.007

P. Brastianos, P. Horowitz, and S. Santagata, Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations, Nature Genetics, vol.146, issue.3, pp.285-289, 2013.
DOI : 10.1038/nature09534

V. Clark, E. Erson-omay, and A. Serin, Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, Science, vol.4339, pp.1077-1080, 2013.

M. Abedalthagafi, W. Bi, and A. Aizer, Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma, Neuro Oncol, 2016.

F. Sahm, D. Schrimpf, and A. Olar, TERT Promoter Mutations and Risk of Recurrence in Meningioma, Journal of the National Cancer Institute, vol.125, issue.3, 2016.
DOI : 10.1007/s00401-014-1370-3

V. E. Clark, Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas, Nature Genetics, vol.37, issue.10, pp.1253-1259, 2016.
DOI : 10.1093/nar/gkp335

S. Rempel, K. Schwechheimer, and R. Davis, Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression, Cancer Res, vol.53, pp.2386-2392, 1993.

N. Peters, R. Wellenreuther, and B. Rollbrocker, Analysis of the PTEN gene in human meningiomas, Neuropathology and Applied Neurobiology, vol.146, issue.1, pp.3-8, 1998.
DOI : 10.3171/jns.1992.77.2.0295

A. Perry, D. Gutmann, and G. Reifenberger, Molecular pathogenesis of meningiomas, Journal of Neuro-Oncology, vol.92, issue.Suppl1, pp.183-202, 2004.
DOI : 10.1016/S0002-9440(10)64222-8

L. Xu, L. Li, and H. Shu, TRAF7 Potentiates MEKK3-induced AP1 and CHOP Activation and Induces Apoptosis, Journal of Biological Chemistry, vol.115, issue.17, p.17278, 2004.
DOI : 10.1038/ncb1086

URL : http://www.jbc.org/content/279/17/17278.full.pdf

T. Zotti, The Emerging Role of TRAF7 in Tumor Development, Journal of Cellular Physiology, vol.286, issue.6, pp.1233-1238, 2017.
DOI : 10.1074/jbc.M110.215426

J. Carpten, A. Faber, C. Horn, G. Donoho, S. Briggs et al., A transforming mutation in the pleckstrin homology domain of AKT1 in cancer, Nature, vol.1, issue.7152, pp.439-483, 2007.
DOI : 10.1128/MCB.17.1.338

J. Ng and T. Curran, The Hedgehog's tale: developing strategies for targeting cancer, Nature Reviews Cancer, vol.137, issue.7, pp.493-501, 2011.
DOI : 10.1242/dev.056358

S. Yuzawa, Genetic landscape of meningioma, Brain Tumor Pathology, vol.22, issue.4, pp.237-247, 2016.
DOI : 10.1097/PAI.0b013e318289f490

J. Vinagre, Frequency of TERT promoter mutations in human cancers, Nature Communications, vol.30, p.2185, 2013.
DOI : 10.1038/onc.2010.512

N. Chalhoub, PTEN and the PI3-Kinase Pathway in Cancer, Annual Review of Pathology: Mechanisms of Disease, vol.4, issue.1, pp.127-150, 2009.
DOI : 10.1146/annurev.pathol.4.110807.092311

M. Preusser, Advances in meningioma genetics: novel therapeutic opportunities, Nature Reviews Neurology, vol.11, issue.2, 2017.
DOI : 10.1016/j.ccr.2013.01.008

J. Boetto, SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas. Neuro Oncol, pp.345-351, 2017.

Ü. Yesilöz, Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence, Neuro-Oncology, vol.125, issue.3, pp.1088-1096, 2017.
DOI : 10.1007/s00401-013-1093-x

K. Jung, M. Fleischhacker, and A. Rabien, Cell-free DNA in the blood as a solid tumor biomarker???A critical appraisal of the literature, Clinica Chimica Acta, vol.411, issue.21-22, pp.1611-1624, 2010.
DOI : 10.1016/j.cca.2010.07.032

D. Pietrasz, N. Pécuchet, E. Fabre, H. Blons, L. Chevalier et al., Quel avenir pour l???ADN tumoral circulant??? ??tat des lieux et perspectives dans les cancers colorectaux, pulmonaires non ?? petites cellules et pancr??atiques, Bulletin du Cancer, vol.103, issue.1, 2016.
DOI : 10.1016/j.bulcan.2015.10.017

C. Tissot, Intérêts de l'ADN circulant pour la prise en charge du cancer bronchopulmonaire, Rev Pneumol Clin, 2015.
DOI : 10.1016/j.pneumo.2015.05.001

V. Van-der, Is the role of circulating DNA as a biomarker of cancer being prematurely overrated? Clin Biochem, pp.26-36, 2010.

E. Zonta, Assessment of DNA Integrity, Applications for Cancer Research, Adv Clin Chem, vol.70, pp.197-246, 2015.
DOI : 10.1016/bs.acc.2015.03.002

L. Jennifer and . Mclarty, Circulating Cell-Free DNA: The Blood Biopsy in Cancer Management, MOJ Cell Sci Rep, vol.2, 2015.

. Kock, High-sensitivity sequencing reveals multi-organ somatic mosaicism causing DICER1 syndrome, J. Med. Genet, p.2016

. Kinde, Detection and quantification of rare mutations with massively parallel sequencing, Proceedings of the National Academy of Sciences, vol.323, issue.5910, pp.9530-9535, 2011.
DOI : 10.1126/science.1162986

M. Zhao, Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives, BMC Bioinformatics, vol.14, issue.Suppl 11, p.14, 2013.
DOI : 10.1186/1471-2105-12-267

M. M. Li, Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, The Journal of Molecular Diagnostics, vol.19, issue.1, pp.4-23, 2017.
DOI : 10.1016/j.jmoldx.2016.10.002

Y. Wang, Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord, Proceedings of the National Academy of Sciences, vol.4, issue.4, 2015.
DOI : 10.1126/science.1210557

F. Sahm, DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis, The Lancet Oncology, vol.18, issue.5, 2017.
DOI : 10.1016/S1470-2045(17)30155-9